Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the
fourth most common malignancy and the second leading cause of tumor-related death …

Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in
China, is the fourth most common malignancy and the second leading cause of tumor …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality worldwide.
Various imaging modalities provide important information about HCC for its clinical …

Hepatocellular carcinoma (HCC) is one of the major causes of morbidity, mortality, and
healthcare expenditure in patients with chronic liver disease in India. The Indian National …

Atezolizumab plus bevacizumab (Atezo/Bev) followed by curative conversion (ABC
conversion) therapy is very effective in the treatment of unresectable, transarterial …

Background Microvascular invasion (MVI) is a critical risk factor for early recurrence of
hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). The aim of this …

Purpose: This work aimed to explore in depth the genomic and molecular underpinnings of
hepatocellular carcinoma (HCC) with increased 2 [18F] fluoro-2-deoxy-d-glucose (FDG) …

Materials and Methods Nineteen HCC patients who underwent 18 F-fluorodeoxyglucose (18
F-FDG) positron emission tomography (PET) as part of restaging procedure also underwent …

Fibroblast activation protein contributes to immunosuppression and resistance to
immunotherapies. This study aimed to compare baseline 68Ga-labeled fibroblast activation …

Imaging with 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed
tomography (PET/CT) is used to determine sites of abnormal glucose metabolism to predict …